2013 Trend: Smarter Computer Validation by Fran Nolan

Having been around when dinosaurs roamed the earth and computer validation was “invented,” I am sorry to say that things haven’t changed that much across the industry. Validation of computer systems was originally expected by regulators and subsequently introduced in the manufacturing (cGMP) and lab systems (GLP) arenas. Clinical departments were loath to adopt validation requirements and, to this day, still seem reluctant to accept these requirements.
Over the years, the “validation community” (QA, IT, business functions, etc.) has been very well intended, with many members attempting to promote the ideas that good software development life cycle (SDLC) practices—including documented testing—made good business sense and we shouldn’t look at computer validation as simply a regulatory requirement. Unfortunately, the validation community as a whole generally failed to get this message across; and to this day, many companies, including many software development organizations within those companies, see validation as a necessary evil to be avoided or minimized at all costs.
Those companies, such as Medidata, who have adopted a more enlightened approach to validation have reaped the benefits of more effective and efficient software development practices and most importantly, higher quality software solutions. In particular, great success has been seen in incorporating validation principles within the SDLC process itself, rather than treating validation as a separate exercise. In addition, more modern development and testing practices, such as those based on the agile methodology, result in higher quality solutions, while still generating the necessary documentation expected by regulators.
In 2013, I see even more companies adopting this smarter approach to computer validation and reaping the benefits of a more effective and efficient validation practice.
More on Fran Nolan
Related posts
Comments in this post
- Nick Hargaden10 days ago
HI Fran
I agree that we would all be better off if we can stop seeing validation or SQA as an “FDA thing”, or a “GAMP thing” and challenge ourselves to be the experts in our fields. In fact we should apply that idea to all our activities!
I’d be interested to hear more on how you are incorporating validation principles within the life cycle. I would also be interested hear how you have found external parties have received agile approaches. My experience is that it still creates some concern and confusion.
Leave a reply
FOLLOW US
- From WordPerfect and Lotus 1-2-3 to the Clinical Cloud Tipping Point
- Has Regulatory Guidance on Risk-Based Monitoring Driven Adoption Yet?
- To Risk-Based Monitor or Not to Risk-Based Monitor
- “When in Rome…” eRA2013: Conferenza di Regolatore Affare e Farmacovigilanza
- Through the Eyes of Clinical Supplies
“Big Data” is often used to ...
From WordPerfect and Lotus 1-2-3 to ...Do you remember WordPerfect and Lot ...
To Risk-Based Monitor or Not to Ris ...Clinical site monitoring accounts f ...
Through the Eyes of Clinical Suppli ...In clinical trials, is there any ta ...
"When in Rome..." eRA2013: Conferen ...The eRA (electronic Regulatory Affa ...
on To Risk-Based Monitor or Not to Risk-Based Monitor
Thanks, Jeff!
on To Risk-Based Monitor or Not to Risk-Based Monitor
One driving factor to suggest is that gov’t and academic organizations have always been forced to do more with less...
on To Risk-Based Monitor or Not to Risk-Based Monitor
I've read a few times, just as you say, that gov’t and academic organizations are implementing risk-based monitoring techniques more...
on 2013 Trend: Smarter Computer Validation
HI Fran
I agree that we would all be better off if we can stop seeing validation or SQA as an...
on Has Regulatory Guidance on Risk-Based Monitoring Driven Adoption Yet?
At Polaris Compliance Consultants, we've seen slow adoption of risk-based monitoring among our clients. Companies are leary of beingo...
CDISC and Industry Standards
Clinical Development
Cloud Computing
EDC
Healthcare
Innovation
Interoperability
IT Security
Late Phase Development
Mobile Computing
Monitoring
Partnerships
Patients and Sites
Planning and Budgeting
Randomization and Trial Supply Management
Regulatory Affairs
Safety Data Capture
Software Development
Study and Protocol Design
Trial Management